A multinational research team led by Columbia University and the La Jolla Institute for Immunology has identified a novel viral target that could help combat the global resurgence of measles.
New images of one of the brain’s fastest-acting proteins—the kainate receptor—are providing critical clues that may lead to targeted therapies for epilepsy and other brain disorders.
A new Science study from Columbia stem cell researchers has found that the liver is the surprising source of a growth factor that keeps bone marrow stem cells healthy.
3-D organoids created from the bladder cancers of patients mimic the characteristics of each patient’s tumor and may be used in the future to identify the best treatment for each patient.
Scientists at Columbia University Vagelos College of Physicians and Surgeons present the most definitive evidence to date that the human brain makes new neurons throughout life.
VP&S researchers will investigate macular degeneration, motor neuron differentiation, loss of tactile acuity, and other topics with funds from the New York State Stem Cell Science program.
CUIMC researchers are helping scientists change the way they study human behavior to focus on the mechanisms that explain how people adopt healthier habits.